Grants per year
Personal profile
Research Interests
Dr. Lukas, sub-specializing in neuro-oncology, is interested in the care of patients with primary brain tumors and spinal cord tumors as well as central nervous system (CNS) metastases. Dr. Lukas's research centers on clinical trials in neuro-oncology. Additionally, he has a strong interest in medical education in the U.S. and internationally and conducts research in neuroscience medical education.
Training Experience
| 2003 | Internship, Cook County Hospital, Chicago |
| 2006 | Residency, University of Chicago Hospitals |
| 2008 | Fellowship, University of Chicago |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Rush University
… → 2002
Research interests keywords
- Brain Cancer / Nervous System Cancer
- Medical Education
- Neuro-Oncology
- Spinal Cord Tumors
- Spinal Oncology
Fingerprint
Dive into the research topics where Rimas Vincas Lukas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #CYNK-001-GBM-002: A Phase I/IIa Open Label, Multicenter, Non- Randomized, Trial to Assess the Safety and Efficacy of CYNK-001 in Combination With Recombinant Human Interleukin-2 in Adults With Recurrent Resection Eligible IDH1 Wild Type Glioblastoma
CTI Clinical Trial and Consulting Services, Celularity Inc
9/7/22 → 9/7/25
Project: Research project
-
IDO1 and Immunotolerance in Glioblastoma
Schiltz, G. E., Wainwright, D. A., Horbinski, C. M., Lukas, R. V., Clutter, M. & Zhai, L.
National Institute of Neurological Disorders and Stroke
6/1/21 → 6/30/27
Project: Research project
-
Combination of Checkpoint inhibition and IDO1 together with Standard radiotherapy or chemoradiotherapy in newly diagnosed glioblastoma
7/1/21 → 7/1/23
Project: Research project
-
Relationship between Psychological Distress an the Efficacy of Immunotherapy in Patients with Glioblastoma
Wainwright, D. A. & Lukas, R. V.
7/1/19 → 6/30/22
Project: Research project
-
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics
Kumthekar, P. U., Avram, M. J., Lassman, A. B., Lin, N. U., Lee, E., Grimm, S. A., Schwartz, M., Bell Burdett, K. L., Lukas, R. V., Dixit, K., Perron, I., Zhang, H., Gradishar, W. J., Pentsova, E. I., Jeyapalan, S., Groves, M. D., Melisko, M. & Raizer, J. J., Mar 14 2023, In: Neuro-oncology. 25, 3, p. 557-565 9 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Building Team Medicine in the Management of CNS Metastases
Baskaran, A. B., Buerki, R. A., Khan, O. H., Gondi, V., Stupp, R., Lukas, R. V. & Villaflor, V. M., Jun 2023, In: Journal of Clinical Medicine. 12, 12, 3901.Research output: Contribution to journal › Article › peer-review
Open Access -
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas
Youngblood, M. W., Tran, A. N., Wang, W., An, S., Scholtens, D., Zhang, L., O'Shea, K., Pokorny, J. L., Magill, S. T., Sachdev, S., Lukas, R. V., Ahmed, A., Unruh, D., Walshon, J., McCortney, K., Wang, Y., Baran, A., Sahm, F., Aldape, K., Chandler, J. P., & 3 others, Mar 14 2023, In: Neuro-oncology. 25, 3, p. 508-519 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
From the ER to the OR: Initial Evaluation of Primary Central Nervous System Lymphoma
Baskaran, A. B., Dixit, K. S., Sonabend, A. W., Horbinski, C. M., Abutalib, S. A. & Lukas, R. V., May 1 2023, In: The neurologist. 28, 3, p. 135-142 8 p.Research output: Contribution to journal › Review article › peer-review
-
HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen
Wu, S. A., Jia, D. T., Schwartz, M., Mulcahy, M., Guo, K., Tate, M. C., Sachdev, S., Kostelecky, N., Escobar, D. J., Brat, D. J., Heimberger, A. B. & Lukas, R. V., May 23 2023, In: CNS oncology. 12, 3, CNS99.Research output: Contribution to journal › Article › peer-review
Open Access